echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Technology for the Chinese medicine formula particle industry high-quality development inserted "wings"

    Technology for the Chinese medicine formula particle industry high-quality development inserted "wings"

    • Last Update: 2020-07-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network Industry Dynamics: Chinese medicine formula particles are the rapid development of Chinese medicine preparations in recent years, it refers to the traditional Chinese medicine drink tablets in line with the norms of concocting as raw materials, after modern pharmaceutical technology extraction, concentration, separation, drying, granulation of pure Chinese pharmaceutical typehas the characteristics of quick effect, good absorption, remarkable effect, easy to carry, and can adapt to the modern fast-paced lifeat present, chinese medicine formula particles have more than 700 species, accounting for 50% of Chinese medicine drink tabletsaccording tostatistics show that in 2019 the size of the domestic Chinese medicine formula particle market reached 20 billion yuan, the industry's annual compound growth rate of more than 40%, far higher than the same period of Chinese medicine tablets 21% growth rate, for the pharmaceutical industry's faster growth of sub-sectors, the market development space is huge, however, there is some controversy surrounding the market potential of Chinese medicine formula particlesat present, the market for the application of Chinese medicine formula particles are mainly concerned about two points: first, the quality of Chinese medicine formula particles is uncertain;, how to crack these development difficulties? Industry development can not be separated from the support of policies and the establishment of quality standards industry believes that the high-quality development of Chinese medicine formula particle industry can not be separated from the support and guidance of policies, as well as the establishment of quality standardsthe Outline of the Strategic Planning For Chinese Medicine (2016-2030) clearly includes Chinese medicine formula particles in the national strategic planning of Chinese medicine, and in August 2016, the National Pharmacopoeia Commission issued the Technical Requirements for Quality Control and Standard development of Chinese Medicine Formula Particles (Draft for Comments), which comprehensively launched the National Standard Research on Chinese Medicine Formula Particles, and a number of enterprises, including 6 pilot enterprises, participated in the national standard researchin November 2019, the National Pharmacopoeia announced the first batch of 160 Chinese medicine formula particles, such as bariatric formula particles, the first batch of 160 Chinese medicine formula particle varieties pilot unified standardswith the national norms unified Chinese medicine formula particle quality standards, will be conducive to improve the market acceptance of formula particles, to help the formula particle industry longer-term developmentin order to ensure the quality of Chinese medicine formula particles, related enterprises are also working hardfor example, there are domestic Chinese medicine formula particle tap, combined with infrared mapping technology, chromatography characteristics fingerprint mapping and online quality control technology research, set up a complete set of Chinese medicine formula particle process and quality standards, to meet the needs of industrial production and clinicalscience and technology for the high-quality development of Chinese medicine formula particle industry inserted "wings" experts pointed out that modern science and technology in the process of helping Chinese medicine formula particle standard unity and quality control, will be the Chinese medicine formula particle industry high-quality development into the "wings"according to the "Chinese medicine formula particle quality control and standard development technical requirements (draft for comments)," which mentions: because Chinese medicine formula particles no longer have the characteristics of the identification of the characteristics of the tablet, should be established to control the drug as an accompanying characteristic map or fingerprint mapcharacteristic map can be evaluated by chromatography peak retention time, peak area ratio, etchigh-efficiency liquid chromatography as the main separation tool established by the fingerprint map of Chinese medicine, and also the recommended method of chinese medicine formula particle publicationin the industry, because of the large sample number of Chinese medicine formula particles, and the complex composition of Traditional Chinese medicine, which also makes the chinese medicine fingerprint map to establish a certain degree of difficulty, and the use of stable performance, high reliability of high-efficiency liquid chromatography, can make the work easy, to ensure that the results of sample testing more accurateformula particles are the key support and development direction of the national field of Chinese medicinewith the support of a series of favorable policies, as well as the upgrading of consumer concepts, the size of the Chinese medicine formula particle market will continue to expand, related testing equipment such as high-efficiency liquid chromatography will also usher in development opportunitiesat the same time, the industry's new requirements and demands will continue to produce, so the relevant equipment manufacturers also need to pulse market trends, seize user demand, continuous innovation and upgrade technology and productsit is understood that in order to meet the needs of customer chinese medicine formula particle quality research, there are currently liquid chromatography manufacturers also joint chromatography supplies application team, and actively provide chinese medicine industry customers with a comprehensive Chinese medicine formula particle solutionsnot only greatly improves data processing efficiency, data traceability, but also reduces verification costs and error rates
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.